US 5,508,186 AGranted

B19 parvovirus capsids

AssigneeThe United States of America as represented by the Secretary of Health and Human Services

InventorsNeal S. Young, Sachiko Kajigaya, Takashi Shimada

Life of this patent

Estimating the term…

Abstract

The present invention relates to a method of producing non-infections parvovirus capsids and to diagnostic assays and vaccines utilizing same. The invention further relates to recombinant baculoviruses encoding parvovirus structural proteins and host cells infected therewith. The invention also relates to a method of packaging and delivering genetic information utilizing the noninfectious capsids.

Claims4

Dependent claims

An isolated empty B19 parvovirus capsid.

Dependencies are inferred from the claim text.

Facts

Application: 07/612,672Filed 14 Nov 1990 · continuation in part
Priority: 14 Nov 1988
Granted: 16 Apr 1996
Term ends: Not estimatedThe source records don’t support an estimate.

Classification26 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A61P 31/02
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: local antiseptics
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
C07K 16/081
Against material from viruses: dNA viruses

Family

Serial270,098Parent of this continuation-in-part · filed 14 Nov 1988
US 5,508,186 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results